Place learning and hippocampal synaptic plasticity in streptozotocin- induced diabetic rats

Diabetes

Volumn 45, Issue 9, 1996, Pages 1259-1266

  Biessels, Geert Jan ^a,b   Kamal, Amer ^c   Ramakers, Geert M ^a   Urban, Ivan J ^a   Spruijt, Berrie M ^a   Erkelens, D Willem ^b   Gispen, Willem Hendrik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LEARNING; MALE; MEMORY; MENTAL PERFORMANCE; NERVE CELL PLASTICITY; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STATISTICAL ANALYSIS; STREPTOZOCIN DIABETES; TASK PERFORMANCE;

EID: 0029821906     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.9.1259     Document Type: Article

References (41)

1. Franceschi M, Cecchetto R, Minicucci F, Smizne S, Baio G, Canal N: Cognitive processes in insulin-dependent diabetes. Diabetes Care 7: 228-231, 1984
2. Helkala E-L, Niskanen L, Viinamaki H, Partanen J, Uusitupa M: Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 18:681-685, 1995
3. Reaven GM, Thompson LW, Nahum D, Haskins E: Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13:16-21, 1990
4. Tun PA, Nathan DM, Perlmuter LC: Cognitive and affective disorders in elderly diabetics. Clin Geriatr Med 6:731-746, 1990
5. Ryan CM: Neurobehavioral complications of type I diabetes: examination of possible risk factors. Diabetes Care 11:86-93, 1988
6. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH: Cerebral function in diabetes mellitus. Diabetologia 37:643-650, 1994
7. Sima AA, Zhang WX, Cherian PV, Chakrabarti S: Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia 35:602-607, 1992
8. Terada M, Yasuda H, Kikkawa R, Koyama N, Yokota T, Shigeta Y: Elertrophysiological study of dorsal column function in streptozocin-induced diabetic rats: comparison with 2,5-hexanedione intoxication. J Neurol Sci 115:58-66, 1993
9. Junker U, Jaggi C, Bestetti G, Rossi GL: Basement membrane of hypothalamus and cortex capillaries from normotensive and spontaneously hypertensive rats with steptozotocin-induced diabetes. Acta Neuropathol (Bert) 65:202-208, 1985
10. Jakobsen J, Sidenius P, Gundersen HJ, Osterby R: Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats. Diabetes 36:597-601, 1987
11. Bellush LL, Reid SG, North D: The functional significance of biochemical alterations in streptozotocin-induced diabetes. Physiol Behav 50:973-981, 1991
12. Bellush LL, Rowland NE: Stress and behavior in streptozotocin diabetic rats: biochemical correlates of passive avoidance learning. Behav Neurosci 103:144-150, 1989
13. Flood JF, Mooradian AD, Morley JE: Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 39:1391-1398, 1990
14. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J: Place navigation is impaired in rats with hippocampal lesions. Nature 297:681-683, 1982
15. McNamara RK, Skelton RW: The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res Rev 18:33-49, 1993
16. Bunsey M, Eichenbaum H: Conservation of hippocampal memory function in rats and humans. Nature 379:255-257, 1996
17. Eichenbaum H, Otto T, Cohen NJ: The hippocampus-what does it do? Behav Neural Biol 57:2-36, 1992
18. Jarrard LE: What does the hippocampus really do? Behav Brain Res 71:1-10, 1995
19. Bliss TV, Collingridge GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39, 1993
20. Barnes CA: Involvement of LTP in memory: are we "searching under the street light." Neuron 15:751-754, 1995
21. Malenka RC: Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78:535-538, 1994
22. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER: Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258:1903-1910, 1992
23. Schulz PE, Cook EP, Johnston D: Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. J Neurosci 14:5325-5337, 1994
24. Zucker RS: Short-term synapticplasticity. Annu Rev Neurosci 12:13-31, 1989
25. De Koning P, Gispen WH: Org 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 8:415-422, 1987
26. Spruijt BM, Josephy M, Van Rijzingen I, Maaswinkel H: The ACTH(4-9) analog Org2766 modulates the behavioral changes induced by NMDA and the NMDA receptor antagonist AP5. J Neurosci 14:3225-3230, 1994
27. Ramakers GM, Urban IJ, De Graan PN, Di Luca M, Cattabeni F, Gispen WH: The impaired long-term potentiation in the CAI field of the hippocampus of cognitive deficient microencephalic rats is restored by D-serine. Neuroscience 54:49-60, 1993
28. Gregersen G: Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients. Diabetologia 4:273-277, 1969
29. Eliasson SG: Nerve conduction changes in experimental diabetes. J Clin Invest 43:2353-2358, 1964
30. Tomlinson DR: The pharmacology of diabetic neuropathy. Diabetes Metab Rev 8:67-84, 1992
31. Cameron NE, Cotter MA: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10:189-224, 1994
32. Van Dam PS, Van Asbeck BS, Erkelens DW, Marx JJM, Gispen WH, Bravenboer B: The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev 11:181-192, 1995
33. Kirn J, Rushovich EH, Thomas TP, Ueda T, Agranoff BW, Greene DA: Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes 40:1545-1554, 1991
34. Leong SF, Leung TK: Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain. Neurochem Res 16:1161-1165, 1991
35. Duckrow RB, Beard DC, Brennan RW: Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18:52-58, 1987
36. Bannerman DM, Good MA, Butcher SP, Ramsay M, Morris RGM: Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378:182-186, 1995
37. Davis S, Butcher SP, Morris RG: The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci 12:21-34, 1992
38. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ: Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79:59-68, 1994
39. Bach ME, Hawkins RD, Osman M, Kandel ER, Mayford M: Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81:905-915, 1995
40. Notvest RR, Inspira JJ: Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in consious diabetic rats. Diabetes 36:500-504, 1087
41. Sima AAF, Yagihashi S: Distal central axonopathy in the spontaneously diabetic BB/Wistar rat: a sequential ultrastructural study. Diabetes Res Clin Pract 1:289-298, 1986